FEATURED/ARCHIVES (05/05/24)
Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy · August 2017
Articles
Case Reports in Psychiatry
Cardiovascular Safety of Central Nervous System Stimulants in Children and Adolescents: Population Based Cohort Study · July 2012
Articles
TheBMJ
Risk of Suicidal Events with Atomoxetine Compared to Stimulant Treatment: A Cohort Study · May 2016
Articles
NCBI>Pediatrics
Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients with Attention Deficit Hyperactivity Disorder · April 2023
Articles
Journal of the Korean Academy of Child and Adolescent Psychiatry
Methylphenidate-Induced Obsessive-Compulsive Symptoms: A Case Report and Review of Literature · February 2017
Articles
Journal of Pediatric Neurosciences
Efficacy Oral Glutamine to Prevent Oral Mucositis and Reduce Hospital Costs During Chemotherapy in Children with Acute Lymphoblastic Leukemia · July 2020
Articles
Asian Pacific Journal of Cancer Prevention
Subjective and Objective Assessments of Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder and the Effects of Methylphenidate Treatment · January 2019
Articles
Biomedical Journal
Effects of Atomoxetine on Growth After 2-Year Treatment among Pediatric Patients with Attention-Deficit/Hyperactivity Disorder · July 2005
Abstracts
Pediatrics
Does Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder Predict Risk of Later Major Depression? · June 2008
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
Neurological Adverse Effects of Methylphenidate May Be Misdiagnosed as Meningoencephalitis · June 2015
Articles
NCBI>BMJ Case Reports
Reduction of Alcohol Drinking in Young Adults by Naltrexone: Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety · February 2015
Articles (Manuscripts-Versions)
PubMed Central>Journal of Clinical Psychiatry
Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics · March 2018
Articles
Canadian Journal of Psychiatry
Psychostimulant Medication Safe in Adolescents with ADHD and Substance Use Disorders (Meetings-Events) · November 2009
Abstracts (Summaries)
Medscape>American Academy of Child and Adolescent Psychiatry
SSRI and SNRI Use during Pregnancy and the Risk of Persistent Pulmonary Hypertension of the Newborn · November 2016
Abstracts
British Journal of Clinical Pharmacology
Atypical Antipsychotic Initiation and the Risk of Type II Diabetes in Children and Adolescents · March 2015
Articles (Manuscripts-Versions)
PubMed Central>Pharmacoepidemiology and Drug Safety
Onset of Abnormal Movements and Cardiovascular Symptoms after Acute Change in Complex Polypharmacy in a Child with Attention-Deficit/Hyperactivity Disorder and Mood Symptoms · October 2012
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
High-Dose Stimulants for Attention Deficit Hyperactivity Disorder: A Review of the Clinical Effectiveness, Safety and Guidelines · March 2016
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
Lipid Disturbances in Adolescents Treated with Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia · May 2019
Abstracts
Journal of Clinical Psychiatry
The Effects of Antipsychotics on Weight Gain, Weight-Related Hormones and Homocysteine in Children and Adolescents: A 1-Year Follow-Up Study · May 2016
Abstracts
European Child and Adolescent Psychiatry
A Cross-Sectional Evaluation of the Effect of Risperidone and Selective Serotonin Reuptake Inhibitors on Bone Mineral Density in Boys · March 2010
Articles (Manuscripts-Versions)
Europe PMC>Journal of Clinical Psychiatry